Biotech | April 06, 2026
Biocon renames Irish step-down subsidiary as Biocon Biologics Ireland
Move aligns global biologics identity under the Biocon Biologics brand
Move aligns global biologics identity under the Biocon Biologics brand
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
The innovation leverages Mitsui Chemicals’ oxygen-permeable InnoCell cell culture plate to efficiently collect bile while reducing stress on liver cells
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
The document, published under the Accelerating Clinical Trials in the EU (ACT EU) initiative, sets out how trials should be conducted when health emergencies disrupt normal research operations
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
